Published in J Oncol Pharm Pract on July 03, 2009
Overestimation of carboplatin doses is avoided by radionuclide GFR measurement. Br J Cancer (2012) 0.77
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2005) 10.42
Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med (2013) 4.32
A predictive model for progression of chronic kidney disease to kidney failure. JAMA (2011) 4.22
Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med (2002) 3.77
Evolving importance of kidney disease: from subspecialty to global health burden. Lancet (2013) 3.30
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics (2003) 3.10
Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation (2005) 3.10
The burden of kidney disease: improving global outcomes. Kidney Int (2004) 2.94
Use of electron-beam sterilized hemodialysis membranes and risk of thrombocytopenia. JAMA (2011) 2.70
Side effects related to cancer treatment: CASE 1. Hepatitis following treatment with gefitinib. J Clin Oncol (2005) 2.35
Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician (2004) 2.27
Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer. J Clin Oncol (2005) 2.25
Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ (2013) 2.24
The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant (2004) 2.18
Understanding recent haemoglobin trials in CKD: methods and lesson learned from CREATE and CHOIR. Nephrol Dial Transplant (2007) 2.15
Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol (2012) 2.15
Open letter to Xi Jinping, President of the People's Republic of China: China's fight against corruption in organ transplantation. Transplantation (2014) 2.11
Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol (2004) 2.04
Use of GFR equations to adjust drug doses in an elderly multi-ethnic group--a cautionary tale. Nephrol Dial Transplant (2007) 2.02
Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill. Am J Respir Crit Care Med (2014) 1.97
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol (2012) 1.90
Vascular calcification in chronic kidney disease. Am J Kidney Dis (2004) 1.81
Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery. J Clin Oncol (2009) 1.78
Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res (2010) 1.77
Epidemiology of acute kidney injury. Clin J Am Soc Nephrol (2008) 1.70
Central vein stenosis: a common problem in patients on hemodialysis. ASAIO J (2005) 1.68
Influence of sex on toxicity and treatment outcome in small-cell lung cancer. J Clin Oncol (2005) 1.66
Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease. Kidney Int (2013) 1.63
The profile of cardiac patients with renal artery stenosis. J Am Coll Cardiol (2004) 1.59
Calciphylaxis in the current era: emerging 'ironic' features? Nephrol Dial Transplant (2010) 1.58
A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial. Clin J Am Soc Nephrol (2011) 1.58
The cost of starting and maintaining a large home hemodialysis program. Kidney Int (2010) 1.53
Survival and dialysis initiation: comparing British Columbia and Scotland registries. Nephrol Dial Transplant (2009) 1.50
Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int (2010) 1.47
Low birth weight and nephron mass and their role in the progression of chronic kidney disease: a case report on identical twins with Alport disease. Nephrol Dial Transplant (2011) 1.45
Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia. Lung Cancer (2004) 1.43
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial. J Cancer Res Clin Oncol (2011) 1.43
Improving outcomes from acute kidney injury. J Am Soc Nephrol (2007) 1.42
A study examining the bias of albumin and albumin/creatinine ratio measurements in urine. Clin Chem Lab Med (2015) 1.42
Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis (2003) 1.40
Treatment of anemia in the diabetic patient with retinopathy and kidney disease. Am J Ophthalmol (2003) 1.40
Improving outcomes of acute kidney injury: report of an initiative. Nat Clin Pract Nephrol (2007) 1.38
A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected population. Nephron Clin Pract (2008) 1.36
Corticosteroid therapy in IgA nephropathy. J Am Soc Nephrol (2012) 1.30
Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified Delphi process. Clin J Am Soc Nephrol (2008) 1.30
A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer. Cancer (2009) 1.30
A framework and key research questions in AKI diagnosis and staging in different environments. Clin J Am Soc Nephrol (2008) 1.27
Improving outcomes from acute kidney injury: report of an initiative. Am J Kidney Dis (2007) 1.26
Incidence and outcomes of acute kidney injury in a referred chronic kidney disease cohort. Nephrol Dial Transplant (2010) 1.25
A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer. Clin Cancer Res (2005) 1.23
Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.21
Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials. Clin J Am Soc Nephrol (2012) 1.20
Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial. J Am Soc Nephrol (2004) 1.19
Cohort profile: the chronic kidney disease prognosis consortium. Int J Epidemiol (2012) 1.16
Improving outcomes from acute kidney injury: report of an initiative. Pediatr Nephrol (2007) 1.15
Kidney function and mortality among patients with left ventricular systolic dysfunction. J Am Soc Nephrol (2005) 1.15
Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease. Cardiovasc Res (2009) 1.15
Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings. Clin J Am Soc Nephrol (2012) 1.13
Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int (2011) 1.13
Patient and technique survival among a Canadian multicenter nocturnal home hemodialysis cohort. Clin J Am Soc Nephrol (2010) 1.13
Policy statement of Canadian Society of Transplantation and Canadian Society of Nephrology on organ trafficking and transplant tourism. Transplantation (2010) 1.13
Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation (2009) 1.12
Effect of early correction of anemia on the progression of CKD. Am J Kidney Dis (2006) 1.12
How to survive the survival plots. Lancet (2002) 1.11
Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr (2010) 1.09
First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer: does sequence matter? Cancer (2006) 1.09
Clinical factors associated with initiation of renal replacement therapy in critically ill patients with acute kidney injury-a prospective multicenter observational study. J Crit Care (2011) 1.08
Differences in progression of CKD and mortality amongst Caucasian, Oriental Asian and South Asian CKD patients. Nephrol Dial Transplant (2010) 1.08
Multi-intervention management of calciphylaxis: a report of 7 cases. Am J Kidney Dis (2011) 1.08
A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect. Am Heart J (2004) 1.08
Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development. PLoS One (2012) 1.06
Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients. BMC Cancer (2007) 1.04
The KRESCENT Program: an initiative to match supply and demand for kidney research in Canada. Clin Invest Med (2010) 1.04
Organ trafficking and transplant tourism: the role of global professional ethical standards-the 2008 Declaration of Istanbul. Transplantation (2013) 1.03
The cardiovascular effects of arteriovenous fistulas in chronic kidney disease: a cause for concern? Semin Dial (2006) 1.03
A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancer. Clin Cancer Res (2012) 1.01
Appraisal of evidence and control of bias in the kidney disease outcomes quality initiative guideline development process. Clin J Am Soc Nephrol (2006) 1.01
Analysis of multidisciplinary care models and interface with primary care in management of chronic kidney disease. Semin Nephrol (2009) 1.01
Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia. Lung Cancer (2008) 0.99
Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North America. Lung Cancer (2005) 0.99
A systematic review of ethnic differences in the rate of renal progression in CKD patients. Nephrol Dial Transplant (2010) 0.99
Thoracic radiotherapy for limited-stage small cell lung cancer: issues of timing, volumes, dose, and fractionation. Semin Oncol (2003) 0.99
Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers. Am Fam Physician (2004) 0.98
Timing the initiation of renal replacement therapy for acute kidney injury in Canadian intensive care units: a multicentre observational study. Can J Anaesth (2012) 0.98
Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortality. Clin J Am Soc Nephrol (2009) 0.97
Nephrology: 4. Strategies for the care of adults with chronic kidney disease. CMAJ (2003) 0.97
Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies. Gynecol Oncol (2006) 0.97
Exploration of association of 1,25-OH2D3 with augmentation index, a composite measure of arterial stiffness. Clin J Am Soc Nephrol (2008) 0.97
Longitudinal analysis of performance of estimated glomerular filtration rate as renal function declines in chronic kidney disease. Nephrol Dial Transplant (2008) 0.96
Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency. Nephrol Dial Transplant (2002) 0.96
Stage I non-small cell lung cancer (NSCLC) in patients aged 75 years and older: does age determine survival after radical treatment? J Thorac Oncol (2010) 0.95
Definition and classification of kidney diseases. Am J Kidney Dis (2013) 0.94
Outcomes of a provincial home haemodialysis programme--a two-year experience: establishing benchmarks for programme evaluation. Nephrol Dial Transplant (2008) 0.94
Development, prevention, and potential reversal of left ventricular hypertrophy in chronic kidney disease. J Am Soc Nephrol (2004) 0.93